Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]

Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]

Zhao Y, Wang H, Yang Y, et al. Int J Nanomedicine. 2020:15:9571–9586 The authors have advised Figure 4F on page 9579 is incorrect. Due to an error at the time of figure assembly the representative image from free E7/CpG group twice instead the image of L...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhao Y, Wang H, Yang Y, Jia W, Su T, Che Y, Feng Y, Yuan X, Wang X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
immunotherapy
human papillomavirus
peptide vaccine
cpg odn adjuvant
liposome
tumor microenvironment
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/d888b0309ef7480488a67bb6342f5f3d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares